Alleviation of insulin resistance and liver damage by oral administration of Imm124-E is mediated by increased Tregs and associated with increased serum GLP-1 and adiponectin: results of a phase I/II clinical trial in NASH

• Príomhchruthaitheoirí: Mizrahi M (Údar), Shabat Y (Údar), Ben Ya'acov A (Údar), Lalazar G (Údar), Adar T (Údar), Wong V (Údar), Muller B (Údar), Rawlin G (Údar), Ilan Y (Údar)
• Formáid: LEABHAR
• Foilsithe / Cruthaithe: Dove Medical Press, 2012-12-01T00:00:00Z.
• Ábhair: article
• Rochtain ar líne: Connect to this object online.

Meir Mizrahi,1 Yehudit Shabat,1 Ami Ben Ya'acov,1 Gadi Lalazar,1 Tomer Adar,1 Victor Wong,2 Brian Muller,2 Grant Rawlin,2 Yaron Ilan11Liver Unit, Hebrew University-Hadassah Medical Center, Jerusalem, Israel; 2Immuron Limited, North Melbourne, AustraliaBackground: Nonalcoholic steatohepatitis...